New cyclic arylguanidine scaffolds as a platform for development of antimicrobial and antiviral agents
Description
According to WHO, infectious diseases are still a significant threat to public health. The combine effects of antibiotic resistance, immunopressure, and mutations within the bacterial and viral genomes necessitates the search for new molecules
